2009
DOI: 10.1016/j.ejmech.2009.03.027
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
35
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 63 publications
(36 citation statements)
references
References 24 publications
(27 reference statements)
1
35
0
Order By: Relevance
“…In contrary to this, the reports on DHP carboxamide derivatives are meager [12]. However, recently, the synthesis and antitubercular activity of new N,N-diaryl-3,5-dicarbamoyl derivatives of 1,4-DHPs and 1,4-DHPs containing different ester substitutes and diethyl carbamoyl groups have been reported [13]. It is also of interest to incorporate some biologically potent heterocycles viz., pyridine [14], quinazolin-4(3H)-one [15], imidazole [16], thiophene [17], furan [18], and pyrrole [19] into the DHP system along with the carboxamide functionality with a regard to obtaining an increased biological potency.…”
Section: Introductionmentioning
confidence: 94%
“…In contrary to this, the reports on DHP carboxamide derivatives are meager [12]. However, recently, the synthesis and antitubercular activity of new N,N-diaryl-3,5-dicarbamoyl derivatives of 1,4-DHPs and 1,4-DHPs containing different ester substitutes and diethyl carbamoyl groups have been reported [13]. It is also of interest to incorporate some biologically potent heterocycles viz., pyridine [14], quinazolin-4(3H)-one [15], imidazole [16], thiophene [17], furan [18], and pyrrole [19] into the DHP system along with the carboxamide functionality with a regard to obtaining an increased biological potency.…”
Section: Introductionmentioning
confidence: 94%
“…Another series of pyridine derivatives were developed by Fassihi et al who synthesized compound 54 (figure 17), a potent anti-TB agent with activity similar to RIF. The results of these compounds showed that an imidazole group as a substituent is equivalent to a nitro phenyl group, which has been reported in anti-TB agents derived from 1,4-dihydropyridinecarboxamides (Fassihi et al, 2009). Another important heterocyclic for the design of anti-TB agents is the pyridazine moiety.…”
Section: Nitrogen Heterocyclic Derivativesmentioning
confidence: 82%
“…A series of derivatives showed that if the pyrimidine ring is substituted in any position or changed by an isosteric, this decreases anti--TB activity. Amino group substitutions by phthalimide ring also lead to a decrease anti--TB activity (32). Modifications in the pyridine ring decrease anti--TB activity.…”
Section: Other Non--nitrogen Heterocyclic Derivativesmentioning
confidence: 99%
“…The results showed that an imidazole group as a substituent is equivalent to a nitro phenyl group, which has been reported in anti--TB agents derived from 1,4--dihydropyridinecarboxamides. 32 Another important heterocyclic for the design of anti--TB compounds is a pyridazine moiety. In these compounds a relationship between Br, Cl and CH3 substituents, respectively, with Br and vinyl has been found with a favorable anti--TB activity.…”
Section: Nitrogen Heterocyclic Derivativesmentioning
confidence: 99%